Since 2022, the number of private equity-backed cardiology platforms has more than doubled, according to a corporate finance report released in October 2024 by KPMG.
Celebration, Fla.-based Cardiovascular Associates of America (CVAUSA), backed by Webster Equity Partners, Chicago-based Cardiovascular Logistics, backed by Lee Equity, and Chicago-based Heart and Vascular Partners, backed by Assured Healthcare partners, are the market’s largest consolidators by both number of practices and geographic coverage, according to the report.
According to the report, 2023 saw the highest deal activity, with 28 mergers and acquisitions.
Here’s a breakdown of cardiology platforms and their acquisitions in 2023:
1. Cardiovascular Associates of America: 9
2. US Heart & Vascular: 6
3. Cardiovascular Logistics: 3
4. Heart & Vascular Partners: 3
5. CLS Health: 2
6. Rubicon Founders: 2
7. Pivotal Healthcare Partners: 2
8. NYU Langone Health: 1
9. Interventional Cardiology Medical Group: 1
10. WindRose Health Investors: 1
11. USA Health: 1
12. Samaritan Medical: 1
13. MDVIP: 1
14. QOROS (Chicago Pacific Founders): 1
15. SCA Health (Optum): 1
16. RC Capital: 1
17: Cristus Health: 1
18. Lee Equity Partners: 1
19. Undisclosed: 1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.